Literature DB >> 8234110

Lymphocytic meningitis as the sole manifestation of Q fever.

A Schattner1, M Kushnir, T Zhornicky, G Fenakel.   

Abstract

A young man who presented with a 3 week history of fever and severe headache accompanied by mild leukocytosis, was found to have lymphocytic meningitis due to Coxiella burnetti. Thus, Q fever can present as lymphocytic (aseptic) meningitis responsive to tetracycline with no evidence of pulmonary involvement.

Entities:  

Mesh:

Year:  1993        PMID: 8234110      PMCID: PMC2399693          DOI: 10.1136/pgmj.69.814.636

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN: 0032-5473            Impact factor:   2.401


  5 in total

1.  The nervous system in Rocky Mountain spotted fever.

Authors:  J Q Miller; T R Price
Journal:  Neurology       Date:  1972-06       Impact factor: 9.910

Review 2.  Q fever: current concepts.

Authors:  L A Sawyer; D B Fishbein; J E McDade
Journal:  Rev Infect Dis       Date:  1987 Sep-Oct

3.  Rocky Mountain spotted fever. A clinical review based on 48 confirmed cases, 1943-1986.

Authors:  J L Kirk; D P Fine; D J Sexton; H G Muchmore
Journal:  Medicine (Baltimore)       Date:  1990-01       Impact factor: 1.889

4.  Rickettsial meningitis and encephalitis.

Authors:  K Silpapojakul; C Ukkachoke; S Krisanapan; K Silpapojakul
Journal:  Arch Intern Med       Date:  1991-09

5.  Acute febrile cerebrovasculitis. A non-spotted fever group rickettsial disease.

Authors:  C C Linnemann; C I Pretzman; E D Peterson
Journal:  Arch Intern Med       Date:  1989-07
  5 in total
  2 in total

Review 1.  Armies of pestilence: CNS infections as potential weapons of mass destruction.

Authors:  B L Hart; L Ketai
Journal:  AJNR Am J Neuroradiol       Date:  2014-12-04       Impact factor: 3.825

Review 2.  From Q Fever to Coxiella burnetii Infection: a Paradigm Change.

Authors:  Carole Eldin; Cléa Mélenotte; Oleg Mediannikov; Eric Ghigo; Matthieu Million; Sophie Edouard; Jean-Louis Mege; Max Maurin; Didier Raoult
Journal:  Clin Microbiol Rev       Date:  2017-01       Impact factor: 26.132

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.